Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 26 January 2006. doi:10.1136/ard.2005.049486
Annals of the Rheumatic Diseases 2006;65:1585-1589
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism.

EXTENDED REPORT

Hippocampal atrophy in systemic lupus erythematosus

S Appenzeller1, A D Carnevalle3, L M Li2, L T L Costallat1, F Cendes2

1 Department of Rheumatology, University of Campinas, São Paulo, Brazil
2 Department of Neurology, University of Campinas, São Paulo, Brazil
3 Neuroimaging Laboratory, University of Campinas, São Paulo, Brazil

Correspondence to:
F Cendes
Department of Neurology, University of Campinas—UNICAMP, Cidade Universitária, Campinas, São Paulo CEP 13083-970, Brazil; fcendes{at}unicamp.br

Objectives: To determine the frequency and progression of hippocampal atrophy in systemic lupus erythematosus (SLE) and the clinical, laboratory and treatment features associated with its occurrence.

Methods: 150 patients with SLE and 40 healthy volunteers were enrolled in our study. A complete clinical, laboratory and neurological evaluation was performed. Magnetic resonance imaging was carried out using a 2T scanner (Elscint Prestige) and coronal T1-weighted images were used for manual volumetric measurements. Atrophy was defined as values <2 standard deviations from the means of controls.

Results: At entry into the study, the mean right and left hippocampal volumes of patients were significantly smaller than the hippocampal volumes of controls (p<0.001). After the follow-up magnetic resonance imaging, a significant progression of reduction in right and left hippocampal volumes in patients was observed (p<0.001). At entry, atrophy was identified in 43.9% and at follow-up in 66.7% of patients with SLE. Hippocampal atrophy was related to disease duration (p<0.001) total corticosteroid dose (p = 0.01) and history of central nervous system (CNS) manifestations (p = 0.01). Progression of atrophy was associated with cumulative corticosteroid dose (p = 0.01) and number of CNS events (p = 0.01). Patients with cognitive impairment had more severe hippocampal atrophy than those without.

Conclusion: Disease duration, total corticosteroid dose and greater number of CNS manifestations were associated with hippocampal atrophy in patients with SLE. A significant progression of hippocampal atrophy related to total corticosteroid dose and number of CNS events was observed. Further studies are necessary to confirm these findings.

Abbreviations: ACR, American College of Rheumatology; CNS, central nervous system; MRI, magnetic resonance imaging; SLE, systemic lupus erythematosus; SLEDAI, Systemic Lupus Erythematous Disease Activity Index; SLICC/ACR DI, Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs